Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-05

Clinical Trial Update: A Study of VI-0521 for the Treatment of Obstructive Sleep Apnea / Hypopnea Syndrome in Obese Adults [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial updates for VI-0521 in obese adults with obstructive sleep apnea, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VI-0521

Snippet

Sponsor: VIVUS LLC | Conditions: Sleep Apnea | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-10-05